TRLIX
Price
$23.99
Change
-$0.11 (-0.46%)
Updated
Aug 15 closing price
Net Assets
6.33B
VIVAX
Price
$70.33
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

TRLIX vs VIVAX

Header iconTRLIX vs VIVAX Comparison
Open Charts TRLIX vs VIVAXBanner chart's image
Nuveen Large Cap Value R6
Price$23.99
Change-$0.11 (-0.46%)
VolumeN/A
Net Assets6.33B
Vanguard Value Index I
Price$70.33
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
TRLIX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TRLIX vs. VIVAX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRLIX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 196B vs. TRLIX (6.33B). VIVAX pays higher dividends than TRLIX: VIVAX (2.06) vs TRLIX (1.36). TRLIX was incepted earlier than VIVAX: TRLIX (23 years) vs VIVAX (33 years). TRLIX (0.41) is less costly to investors than VIVAX (0.17). TRLIX is a more actively managed with annual turnover of: 19.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than TRLIX: VIVAX (3000) vs TRLIX (1000000). VIVAX (7.90) and TRLIX (7.87) have marching annual gain over last year. VIVAX return over 5 years is better than : 68.56 vs. TRLIX (54.20).
TRLIXVIVAXTRLIX / VIVAX
Total Expense Ratio0.410.17241%
Annual Report Gross Expense Ratio0.410.17241%
Fund Existence23 years33 years-
Gain YTD8.6506.512133%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets6.33B196B3%
Annual Yield % from dividends1.362.0666%
Returns for 1 year7.877.90100%
Returns for 3 years20.2425.9378%
Returns for 5 years54.2068.5679%
Returns for 10 years44.39114.6439%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPHAX24.890.35
+1.43%
Fidelity Select Pharmaceuticals Port
QALGX37.48N/A
N/A
Federated Hermes MDT Large Cap Growth A
ETIEX13.46-0.01
-0.07%
Eventide Exponential Technologies I
PEQSX37.57-0.08
-0.21%
Putnam Large Cap Value R6
LSRCX1.85-0.02
-1.07%
Lord Abbett Small Cap Value C